Psyence Biomedical (PBM) Competitors $0.62 -0.05 (-6.78%) Closing price 04:00 PM EasternExtended Trading$0.62 -0.01 (-1.38%) As of 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends PBM vs. QNTM, CSCI, BCDA, BMRA, MBRX, CING, INDP, NERV, SNSE, and BLRXShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Quantum Biopharma (QNTM), COSCIENS Biopharma (CSCI), BioCardia (BCDA), Biomerica (BMRA), Moleculin Biotech (MBRX), Cingulate (CING), Indaptus Therapeutics (INDP), Minerva Neurosciences (NERV), Sensei Biotherapeutics (SNSE), and BioLineRx (BLRX). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Quantum Biopharma COSCIENS Biopharma BioCardia Biomerica Moleculin Biotech Cingulate Indaptus Therapeutics Minerva Neurosciences Sensei Biotherapeutics BioLineRx Quantum Biopharma (NASDAQ:QNTM) and Psyence Biomedical (NASDAQ:PBM) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations. Does the media favor QNTM or PBM? In the previous week, Quantum Biopharma had 2 more articles in the media than Psyence Biomedical. MarketBeat recorded 2 mentions for Quantum Biopharma and 0 mentions for Psyence Biomedical. Quantum Biopharma's average media sentiment score of 0.00 equaled Psyence Biomedical'saverage media sentiment score. Company Overall Sentiment Quantum Biopharma Neutral Psyence Biomedical Neutral Which has preferable earnings & valuation, QNTM or PBM? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQuantum BiopharmaN/AN/A-$17.90M-$15.41-0.37Psyence BiomedicalN/AN/A-$51.16MN/AN/A Does the MarketBeat Community favor QNTM or PBM? Quantum Biopharma and Psyence Biomedical both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformQuantum BiopharmaN/AN/APsyence BiomedicalN/AN/A Which has more risk & volatility, QNTM or PBM? Quantum Biopharma has a beta of 0.37, meaning that its stock price is 63% less volatile than the S&P 500. Comparatively, Psyence Biomedical has a beta of -0.45, meaning that its stock price is 145% less volatile than the S&P 500. Do institutionals and insiders have more ownership in QNTM or PBM? 1.2% of Quantum Biopharma shares are held by institutional investors. Comparatively, 77.4% of Psyence Biomedical shares are held by institutional investors. 8.5% of Quantum Biopharma shares are held by insiders. Comparatively, 3.6% of Psyence Biomedical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Is QNTM or PBM more profitable? Psyence Biomedical's return on equity of 0.00% beat Quantum Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Quantum BiopharmaN/A -84.21% -62.63% Psyence Biomedical N/A N/A N/A SummaryQuantum Biopharma beats Psyence Biomedical on 4 of the 7 factors compared between the two stocks. Remove Ads Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.83M$7.07B$5.70B$8.12BDividend YieldN/A2.73%4.41%4.09%P/E RatioN/A6.2724.1518.94Price / SalesN/A235.75394.5890.48Price / CashN/A65.6738.1634.64Price / Book-0.016.737.104.43Net Income-$51.16M$141.91M$3.19B$247.05M7 Day Performance-20.32%3.31%1.79%1.48%1 Month Performance-51.95%-4.55%2.32%-6.41%1 Year Performance-99.28%-3.76%14.79%3.33% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$0.62-6.8%N/A-99.2%$2.83MN/A0.00N/AGap DownQNTMQuantum BiopharmaN/A$6.50-9.5%N/AN/A$12.47MN/A-0.42N/AUpcoming EarningsNews CoverageGap DownCSCICOSCIENS BiopharmaN/A$3.25+2.2%N/AN/A$12.28M$7.60M-0.2720Upcoming EarningsGap DownBCDABioCardia3.0877 of 5 stars$2.66+1.5%$25.00+839.8%-58.8%$12.19M$71,000.00-0.6440Upcoming EarningsGap UpBMRABiomerica0.4594 of 5 stars$0.66-6.1%N/A-34.3%$12.05M$5.58M-1.9360MBRXMoleculin Biotech2.0761 of 5 stars$1.09-3.5%$18.67+1,612.5%-82.7%$11.83MN/A0.0020Gap DownCINGCingulate3.0263 of 5 stars$3.65-1.4%$16.00+338.4%+278.7%$11.72MN/A0.0020News CoverageGap UpINDPIndaptus Therapeutics3.0059 of 5 stars$0.81-0.3%$8.50+949.4%-67.4%$11.44MN/A-0.476News CoverageHigh Trading VolumeNERVMinerva Neurosciences2.8367 of 5 stars$1.63+4.5%$5.00+206.7%-35.9%$11.40MN/A-3.709Analyst ForecastNews CoverageSNSESensei Biotherapeutics4.6481 of 5 stars$0.44-0.5%$4.33+884.8%-57.8%$11.07MN/A-0.3740Upcoming EarningsShort Interest ↓Positive NewsGap DownBLRXBioLineRx1.505 of 5 stars$3.18-1.2%$360.00+11,220.8%-92.8%$10.59M$21.99M-0.3640 Remove Ads Related Companies and Tools Related Companies Quantum Biopharma Alternatives COSCIENS Biopharma Alternatives BioCardia Alternatives Biomerica Alternatives Moleculin Biotech Alternatives Cingulate Alternatives Indaptus Therapeutics Alternatives Minerva Neurosciences Alternatives Sensei Biotherapeutics Alternatives BioLineRx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBM) was last updated on 3/21/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredTrump doesn’t give a damnPorter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met...Porter & Company | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBM Stock Alerts